Stock listing
Frankfurt:7U5 Bioton S.A. Aktie
German listing (Frankfurt) of Bioton S.A. · home listing GPW:BIO
Follow Bioton S.A. into a list and get an email when it puts out news.
Share price · FWB:7U5
€0.732 EUR -0.014 (-1.9%)
Close on Nov 20, 2026
- Day range
- €0.732 – €0.732 EURNov 20, 2026
- Market cap
- €62.85M EURAt the close on Nov 20, 2026 · price × 85.86M shares outstanding
- 52-week range
- €0.719 – €1.036 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €150 EURMedian day 0 shares · 55 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| GPW:BIO · Home | 3.34 PLN | -0.12 (-3.5%) | 30,436 | 3.405 | 3.42 | 3.31 | 3.46 | Close on Nov 20, 2026 |
| Frankfurt:7U5 | €0.732 EUR | -0.014 (-1.9%) | — | €0.732 | €0.732 | €0.732 | €0.746 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:7U5 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.755 | -0.006 | -0.8% | €0.755 | €0.755 | €0.755 | 0 | |
| €0.761 | +0.020 | +2.7% | €0.761 | €0.761 | €0.761 | 0 | |
| €0.741 | +0.022 | +3.1% | €0.741 | €0.741 | €0.741 | 0 | |
| €0.719 | -0.014 | -1.9% | €0.719 | €0.719 | €0.719 | 0 | |
| €0.733 | -0.059 | -7.4% | €0.733 | €0.733 | €0.733 | 5,600 | |
| €0.792 | +0.013 | +1.7% | €0.793 | €0.794 | €0.791 | 5,600 | |
| €0.779 | -0.019 | -2.4% | €0.779 | €0.779 | €0.779 | 0 | |
| €0.798 | +0.007 | +0.9% | €0.798 | €0.798 | €0.798 | 0 | |
| €0.791 | -0.010 | -1.2% | €0.791 | €0.791 | €0.791 | 0 | |
| €0.801 | -0.004 | -0.5% | €0.801 | €0.801 | €0.801 | 0 | |
| €0.805 | +0.001 | +0.1% | €0.805 | €0.805 | €0.805 | 0 | |
| €0.804 | -0.011 | -1.3% | €0.804 | €0.804 | €0.804 | 0 | |
| €0.815 | -0.007 | -0.9% | €0.815 | €0.815 | €0.815 | 0 | |
| €0.822 | +0.008 | +1.0% | €0.822 | €0.822 | €0.822 | 0 | |
| €0.814 | 0.000 | 0.0% | €0.814 | €0.814 | €0.814 | 0 | |
| €0.814 | -0.012 | -1.5% | €0.814 | €0.814 | €0.814 | 0 | |
| €0.826 | +0.005 | +0.6% | €0.826 | €0.826 | €0.826 | 0 | |
| €0.821 | -0.021 | -2.5% | €0.821 | €0.821 | €0.821 | 0 | |
| €0.842 | +0.014 | +1.7% | €0.842 | €0.842 | €0.842 | 0 | |
| €0.828 | -0.013 | -1.5% | €0.828 | €0.828 | €0.828 | 0 | |
| €0.841 | -0.017 | -2.0% | €0.841 | €0.841 | €0.841 | 0 | |
| €0.858 | +0.005 | +0.6% | €0.858 | €0.858 | €0.858 | 0 | |
| €0.853 | +0.006 | +0.7% | €0.853 | €0.853 | €0.853 | 0 | |
| €0.847 | +0.019 | +2.3% | €0.847 | €0.847 | €0.847 | 0 | |
| €0.828 | +0.012 | +1.5% | €0.828 | €0.828 | €0.828 | 0 | |
| €0.816 | -0.014 | -1.7% | €0.816 | €0.816 | €0.816 | 0 | |
| €0.830 | -0.005 | -0.6% | €0.830 | €0.830 | €0.830 | 0 | |
| €0.835 | +0.002 | +0.2% | €0.835 | €0.835 | €0.835 | 0 | |
| €0.833 | +0.057 | +7.3% | €0.833 | €0.833 | €0.833 | 0 | |
| €0.776 | +0.020 | +2.6% | €0.776 | €0.776 | €0.776 | 0 | |
| €0.756 | -0.016 | -2.1% | €0.756 | €0.756 | €0.756 | 0 | |
| €0.772 | -0.013 | -1.7% | €0.772 | €0.772 | €0.772 | 0 | |
| €0.785 | +0.015 | +1.9% | €0.785 | €0.785 | €0.785 | 0 | |
| €0.770 | +0.007 | +0.9% | €0.770 | €0.770 | €0.770 | 0 | |
| €0.763 | +0.001 | +0.1% | €0.763 | €0.763 | €0.763 | 0 | |
| €0.762 | -0.009 | -1.2% | €0.762 | €0.762 | €0.762 | 0 | |
| €0.771 | -0.041 | -5.0% | €0.771 | €0.771 | €0.771 | 0 | |
| €0.812 | 0.000 | 0.0% | €0.812 | €0.812 | €0.812 | 0 | |
| €0.812 | -0.012 | -1.5% | €0.812 | €0.812 | €0.812 | 0 | |
| €0.824 | -0.006 | -0.7% | €0.824 | €0.824 | €0.824 | 0 | |
| €0.830 | -0.016 | -1.9% | €0.830 | €0.830 | €0.830 | 0 | |
| €0.846 | -0.002 | -0.2% | €0.846 | €0.846 | €0.846 | 0 | |
| €0.848 | -0.002 | -0.2% | €0.848 | €0.848 | €0.848 | 0 | |
| €0.850 | +0.002 | +0.2% | €0.850 | €0.850 | €0.850 | 0 | |
| €0.848 | -0.001 | -0.1% | €0.848 | €0.848 | €0.848 | 0 | |
| €0.849 | +0.005 | +0.6% | €0.849 | €0.849 | €0.849 | 0 | |
| €0.844 | +0.024 | +2.9% | €0.844 | €0.844 | €0.844 | 0 | |
| €0.820 | -0.010 | -1.2% | €0.820 | €0.820 | €0.820 | 0 | |
| €0.830 | -0.005 | -0.6% | €0.830 | €0.830 | €0.830 | 0 | |
| €0.835 | +0.001 | +0.1% | €0.835 | €0.835 | €0.835 | 0 | |
| €0.834 | +0.001 | +0.1% | €0.834 | €0.834 | €0.834 | 0 | |
| €0.833 | -0.001 | -0.1% | €0.833 | €0.833 | €0.833 | 0 | |
| €0.834 | +0.001 | +0.1% | €0.834 | €0.834 | €0.834 | 0 | |
| €0.833 | 0.000 | 0.0% | €0.833 | €0.833 | €0.833 | 0 | |
| €0.833 | -0.009 | -1.1% | €0.833 | €0.833 | €0.833 | 0 | |
| €0.842 | +0.003 | +0.4% | €0.842 | €0.842 | €0.842 | 0 | |
| €0.839 | +0.004 | +0.5% | €0.839 | €0.839 | €0.839 | 0 |
- Ticker
- Frankfurt:7U5
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · May 29, 2026
Bioton Q1 Net Loss At 5.2 Million Zlotys
Latest news
Bioton Q1 Net Loss At 5.2 Million Zlotys
May 29, 2026
Closed €0.945 (+2.1%) on May 29, 2026
Bioton Says Polish Court Declares Chinese Arbitral Award Enforceable
May 27, 2026
Closed €0.993 (0.0%) on May 27, 2026
Bioton EGM To Vote On Reducing Share Capital To About 8.59 Mln Zlotys From About 1.72 Bln Zlotys
Mar 16, 2026
Closed €0.932 (-0.7%) on Mar 17, 2026
Bioton Q4 Net Profit At 1.8 Mln Zlotys
Feb 27, 2026
Closed €1.01 (+1.5%) on Mar 2, 2026
Bioton S.A. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 4 in the last 12 months · 6 in all · newest May 29, 2026 · oldest 2025
Where Bioton S.A. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| GPW:BIO · Home listing | GPW | Poland | PLN |
| Lang & Schwarz:A0D9SD | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0D9SD | LS Exchange | Germany | EUR |
| LSE:0DTR | LSE | United Kingdom | PLN |
| Frankfurt:7U5 · This page | Frankfurt | Germany | EUR |
| Stuttgart:7U5 | Stuttgart | Germany | EUR |
Valuation
EV/sales 1.4× against a median of 12.4×: 2nd lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 352.8M PLN
- P/E
- Loss
- EV/sales
- 1.4×
- EV/EBITDA
- 6.5×
- Price/book
- 0.5×
- Gross margin
- 38.9%
- Operating margin
- 6.0%
- Net margin
- −3.3%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bioton S.A. · GPW:BIO | US$70.64M | US$86.90M | n/a | 1.4× | 6.5× | 0.5× | −3.3% | 0.1× | n/a |
| Pentixapharm Holding AG · XETR:PTP | US$73.87M | US$69.92M | n/a | 1,158× | n/a | 2.4× | n/a | 0.0× | n/a |
| Dimerix Limited · ASX:DXB | US$73.52M | US$62.98M | n/a | 21.9× | n/a | n/a | −685.3% | n/a | n/a |
| Faron Pharmaceuticals Oy · LSE:FARN | US$72.99M | US$57.36M | n/a | n/a | n/a | 5.7× | n/a | 1.5× | n/a |
| Cellectis S.A. · EURONEXT:ALCLS | US$72.64M | −US$9.64M | n/a | −0.2× | n/a | 1.8× | −115.4% | 2.1× | n/a |
| Kanaph Therapeutics Inc. · KRX:0082N0 | US$72.37M | US$38.83M | n/a | 9.3× | n/a | 2.1× | −729.8% | 0.0× | n/a |
| Eastwood Bio-Medical Canada Inc · TSXV:EBM | US$72.05M | US$72.05M | n/a | 127× | n/a | n/a | −28.5% | n/a | 0.56 |
| SynAct Pharma AB · OMXSTO:SYNACT | US$71.29M | US$71.60M | n/a | n/a | n/a | 5.1× | n/a | 0.3× | n/a |
| Coya Therapeutics, Inc. · NASDAQ:COYA | US$69.20M | US$33.40M | n/a | 7.1× | n/a | 2.1× | −643.5% | 0.0× | 1.64 |
| MAIA Biotechnology, Inc. · AMEX:MAIA | US$68.54M | US$68.54M | n/a | n/a | n/a | 4.7× | n/a | 0.0× | 1.62 |
| ABIONYX Pharma SA · EURONEXT:ABNX | US$68.36M | US$55.53M | n/a | 12.4× | n/a | 4.0× | −136.6% | 1.0× | n/a |
| Median of the others | US$72.21M | US$60.17M | 12.4× | 3.2× | −390.0% | 0.2× | 1.62 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | Mar 28, 2025 | +2.1% |
| Q3 2024 | Nov 8, 2024 | −6.4% |
| Q2 2024 | Aug 27, 2024 | −1.7% |
| Q1 2024 | Apr 30, 2024 | −0.1% |
| Q4 2023 | Mar 29, 2024 | −0.3% |
| Q3 2023 | Oct 31, 2023 | −0.5% |
| Q2 2023 | Aug 31, 2023 | +0.3% |
| Q1 2023 | Apr 28, 2023 | −4.5% |
| Q3 2022 | Oct 31, 2022 | −4.7% |
| Q2 2022 | Aug 31, 2022 | −5.4% |
All 15 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2022 | May 16, 2022 | −0.7% |
| Q3 2021 | Oct 29, 2021 | +0.1% |
| Quarter to Jun 30, 2021 | Aug 31, 2021 | −2.5% |
| Quarter to Mar 31, 2021 | May 19, 2021 | −1.7% |
| Quarter to Dec 31, 2020 | Mar 26, 2021 | +3.5% |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 282.5M | 207.8M | 181.6M | 233.2M | 163.0M | 221.8M | 202.0M | 241.2M | 361.6M | 277.6M |
| Cost of revenue | 185.8M | 142.9M | 108.8M | 126.2M | 80.3M | 113.7M | 93.9M | 125.0M | 175.4M | 139.6M |
| Gross profit | 96.7M | 64.8M | 72.9M | 95.8M | 77.8M | 104.7M | 102.2M | 116.1M | 186.3M | 138.0M |
| Research and development | 3.98M | 4.04M | 5.50M | 5.34M | 4.67M | 4.00M | 6.84M | 33.0M | 8.85M | 7.59M |
| Selling, general and administrative | 36.3M | 31.1M | 30.5M | 30.3M | 27.9M | 38.8M | 38.6M | 50.8M | 54.0M | 54.0M |
| Operating income | 12.8M | -5.71M | 15.3M | 21.3M | 14.3M | 48.6M | 163.5M | -52.4M | 18.0M | -13.9M |
| Depreciation and amortization | 38.5M | 36.3M | 35.0M | 34.4M | 31.6M | 31.7M | 32.3M | 29.5M | 33.4M | 31.3M |
| EBITDA | 51.3M | 30.6M | 50.3M | 55.7M | 46.0M | 80.3M | 195.8M | -22.9M | 51.5M | 17.4M |
| Interest expense | 5.85M | 8.16M | 8.43M | 16.3M | 6.01M | 8.11M | 7.76M | 7.80M | 11.3M | 10.9M |
| Income before tax | 7.83M | -11.9M | 7.23M | 4.95M | 8.33M | 41.6M | 162.1M | 15.2M | -5.84M | -20.8M |
| Income tax | 4.44M | 3.78M | 4.96M | 3.53M | 5.45M | 7.69M | 35.4M | -10.9M | 8.62M | -4.81M |
| Net income | 3.39M | -15.7M | 2.27M | 1.42M | 2.88M | 33.9M | -126.7M | 26.3M | -7.27M | -28.6M |
| Earnings per share, basic | 0.04 | -0.18 | 0.03 | 0.02 | 0.03 | 0.40 | -1.48 | 0.31 | -0.08 | -0.33 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.28M | 6.96M | 3.88M | 9.34M | 8.86M | 22.2M | 7.18M | 7.75M | 38.7M | 88.6M |
| Short-term investments | 1.72M | 32.0M | ||||||||
| Receivables | 37.8M | 27.0M | 36.5M | 31.4M | 39.1M | 37.9M | 48.5M | 53.7M | 92.8M | 74.9M |
| Inventory | 95.0M | 107.3M | 117.9M | 111.0M | 125.1M | 90.0M | 79.7M | 76.8M | 104.6M | 116.8M |
| Current assets | 145.1M | 154.0M | 166.8M | 153.1M | 174.7M | 151.3M | 137.5M | 150.7M | 252.1M | 365.5M |
| Property, plant and equipment | 275.1M | 286.6M | 310.0M | 327.2M | 336.4M | 341.9M | 344.4M | |||
| Goodwill | 0 | 55.5M | 55.5M | 55.5M | ||||||
| Total assets | 764.6M | 794.1M | 822.2M | 810.3M | 848.1M | 867.1M | 885.1M | 1.01B | 1.14B | 1.30B |
| Accounts payable | 17.9M | 37.9M | 33.1M | 36.1M | 36.9M | 50.0M | 77.7M | 41.8M | 38.5M | 72.5M |
| Current liabilities | 102.9M | 143.1M | 165.6M | 141.1M | 166.1M | 157.3M | 197.0M | 174.1M | 258.5M | 342.6M |
| Long-term debt | 7.27M | 0 | 1.70M | 6.81M | 16.1M | 25.1M | 40.6M | 16.9M | 19.6M | 40.4M |
| Total debt | 57.2M | 56.6M | 68.7M | 76.4M | 110.1M | 110.1M | 127.4M | 111.6M | 198.2M | 229.2M |
| Total liabilities | 170.6M | 203.6M | 215.9M | 204.3M | 242.4M | 247.5M | 299.4M | 297.2M | 368.7M | 481.4M |
| Shareholders' equity | 594.0M | 590.5M | 606.4M | 606.1M | 604.5M | 619.6M | 585.3M | 712.8M | 788.8M | 831.0M |
| Shares outstanding | 85.9M | 85.9M | 85.9M | 85.9M | 85.9M | 85.9M | 85.9M | 85.9M | 85.9M | 85.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 22.6M | 36.3M | 39.6M | 56.1M | 5.52M | 41.9M | 46.7M | 27.9M | 17.5M | 23.1M |
| Capital spending | -13.1M | -11.6M | -44.2M | -29.6M | -12.9M | -4.68M | -53.5M | -43.4M | -33.7M | -24.4M |
| Free cash flow | 2.28M | 24.7M | -4.54M | 26.5M | -7.37M | 37.3M | -6.75M | -15.6M | -16.2M | -1.27M |
| Cash from investing | -13.0M | -11.6M | -37.0M | -29.1M | -4.28M | -4.68M | -53.8M | 37.5M | -24.9M | 2.51M |
| Cash from financing | -1.01M | -21.6M | -8.13M | -26.5M | -14.6M | -22.2M | 6.53M | -96.3M | -43.8M | 31.7M |
| Share buybacks | 311.0K | |||||||||
| Change in cash | 1.32M | 3.08M | -5.46M | 483.0K | -13.4M | 15.1M | -568.0K | -30.9M | -51.2M | 57.4M |
Cap table
Built by 6ix from Bioton S.A.’s releases
- Common shares
- 85,864,200
- Fully diluted
- 85,864,200
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 85,864,200 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 85,864,200 |
Log in to ask 6ix AI your own questions about Bioton S.A.